Neck node dissection in thyroid cancer. A review by Pisello, Franco et al.




Regional lymph node metastases are present at the
time of diagnosis in 20-90% of patients with papillary
thyroid carcinoma (PTC) and a lesser proportion of pa-
tients with other histotypes. In many cases, these lymph
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Introduction: thyroid cancer recurs most commonly in one or more
cervical lymph nodes. Surgical treatment for differentiated or medullary
thyroid carcinoma consists of total thyroidectomy (TT). The aim is to elu-
cidate the potential benefits and drawbacks of neck dissection TT related.
Materials and methods: differences between therapeutic and prophy-
lactic neck dissection were analysed to prevent post-operative morbidity,
neck recurrences and improve survival.
Discussion: there is considerable controversy regarding the treatment
of patients with cervical node metastases specially in differentiated thy-
roid cancer. Considering that a neck dissection might help to reduce lo-
cal recurrence, especially in medullary carcinoma, controversial remains
regarding the modality and extension of cervical dissection. There are
several surgical strategies to cervical lymphadenectomy as a prophylac-
tic node dissection or a dissection only in symptomatic patients or the
“node-picking” technique for selective lymphadenectomy or sentinel no-
de biopsy. So it is possible to employ several kind of neck-node compartment
related dissection. The risk of iatrogenic lesion during neck dissection is
relatively high specially for nerve structures (i.e.: recurrent laryngeal ner-
ve or spinal accessory nerve), so an experienced surgeon must mind the
risk is higher during a re-operation in an anatomical subverted region.
Conclusions: the extent of dissection and the experience of the sur-
geon both play important roles in determining the risk of surgical com-
plications and recurrence. The decision to add neck dissection to total
thyroidectomy weighed against documented benefits and risks. Injuries
may also occur as a result of inadequate technique or as a result of poor
expertise of the surgeon. We believe that deep knowledge of the thyroid
region’s surgical anatomy is necessary to realize a skilled and careful sur-
gery of the neck.
RIASSUNTO: La dissezione laterocervicale nei carcinomi della
tiroide. Revisione della letteratura.
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Introduzione. I carcinomi della tiroide metastatizzano frequentemente
ai linfonodi cervicali e poichè il trattamento chirurgico standard prevede
la tiroidectomia totale con linfoadenectomia secondo l'istotipo del tumo-
re, scopo della nostra revisione della letteratura è valutare i potenziali ri-
schi e benefici della linfoadenectomia associata alla tiroidectomia totale. 
Pazienti e metodi. Sono state valutate le differenze tra la linfoade-
nectomia profilattica e terapeutica in termini di morbidità post-opera-
toria, recidiva e sopravvivenza.
Discussione. Ad oggi non c'è concordanza sul trattamento dei pa-
zienti con metastatsi ai linfonodi cervicali, specialmente in quelli con neo-
plasie tiroidee differenziate. Considerando che la dissezione linfonodale
del collo può aiutare a ridurre la recidiva locale, specialmente davanti a
carcinomi midollari della tiroide, controversie rimangono comunque sul
tipo di linfoadenectomia da eseguire. Sono descritte linfoadenectomie pro-
filattiche e dissezioni solo nei pazienti sintomatici, la tecnica “node-picking”
e quella del linfonodo sentinella, che possono essere utilizzate in sinergia.
Va ricordato però il rischio di danno iatrogenico alle strutture nervose
(nervo laringeo inferiore e nervo accessorio spinale) specie nei reinterventi.
Conclusioni. L’estensione della linfoadenectomia laterocervicale e l'e-
sperienza del chirurgo sono fondamentali nel determinismo del rischio
chirurgico stesso e nella incidenza di recidive e la decisione di eseguire
una linfoadenectomia deve considerare i potenziali vantaggi e svantag-
gi, poiché lesioni nervose sono spesso causate da tecnica inadeguata o da
poca esperienza dell'équipe chirurgica. Siamo certi che una profonda co-
noscenza anatomo-chirurgica delle regioni del collo sia fondamentale per
potere eseguire in sicurezza la dissezione dei linfonodi del collo, indi-
pendendentemente dall'istotipo della neoplasia. 
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nodes do not appear abnormal to inspection (1-7). The
role of neck dissection in differentiated thyroid cancer
remains controversial (3). Surgical treatment for diffe-
rentiated (papillary and follicular) or medullary thyroid
carcinoma consists of TT (2). An additional central or
lateral modified-radical neck dissection might help to
reduce local recurrence, especially in medullary thyroid
carcinoma (MTC), but still does not influence signifi-
cantly the survival rates (4). The prophylactic lymph no-
de dissection is not indicated for patients with PTC or
follicular thyroid cancer (FTC) because the nodal me-
tastases can be removed when they become symptoma-
tic, and the overall survival is comparable to that of pa-
tients treated therapeutically. It was also reported that
nodal metastases is a significant risk factor for a poor out-
come in particularly patients and that prophylactic neck
dissection improves the prognosis (1). Today there isn’t
any controversy regarding the treatment of choice for
patients with cervical metastases from differentiated thy-
roid cancer: disease in the central compartment requi-
res a TT and central compartment neck dissection. Su-
spected or proven lateral compartment metastases should
be treated by selective neck dissection (1). The role of
“node-picking” is still controversy. In our opinion the-
re is no role for node-picking. Other Authors  think that
the node-picking is equally effective as more radical sur-
gical procedures (8). Sentinel node biopsy plays no ro-
le and neither does elective lateral compartment surgery
in patients with no clinical or radiological evidence of
disease (5). However, the surgeon must considerate the
re-operation risks of nerve injuries during neck dissec-
tion. 
Lymph nodes in the neck and neck
dissection classification
To describe the lymph nodes of the neck is necessary
to subdivide anatomically the neck into 6 areas called le-
vels. A further level VII to denote lymph node group in
the superior mediastinum is no longer used (9) (Fig. 1). 
• Level I: includes the submental and submandibu-
lar lymph nodes. The submental triangle (sublevel IA)
is bounded by the anterior belly of the digastric muscles
(laterally) and the hyoid (inferiorly). The submandibu-
lar triangle (sublevel IB) is bounded by the body of the
mandible (superiorly), the stylohyoid muscle (posteriorly)
and the anterior belly of the digastric (anteriorly). 
Fig. 1 - Musholt TJ,  Moley JF. Management of recurrent medullary thyroid carcinoma after total thyroidectomy. Prob Gen Surg 1997; 14: 89-110.
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• Level II: includes lymph nodes of the upper jugu-
lar group and is divided into sublevels IIA and IIB. Le-
vel II is bounded by the inferior border of the hyoid (in-
feriorly), the base of skull (superiorly), the stylohyoid
muscle (anteriorly) and the posterior border of the ster-
nocleidomastoid muscle (SCM) (posteriorly). Sublevel
IIA nodes lie anterior to the Spinal Accessory Nerve
(SAN). Sublevel IIB nodes lie posterior to the SAN. 
• Level III: includes lymph nodes of the middle ju-
gular group. This level is bounded by the inferior bor-
der of the hyoid (superiorly) and the inferior border of
the cricoid (inferiorly), the posterior border of the ster-
nohyoid muscle (anteriorly) and the posterior border of
the SCM (posteriorly). 
• Level IV: includes lymph nodes of the lower jugular
group. This level is bounded by the inferior border of
the cricoid (superiorly), the clavicle/sternal notch (in-
feriorly), the posterior border of the sternohyoid mu-
scle (anteriorly) and the posterior border of the SCM
(posteriorly). 
• Level V: includes posterior compartment lymph no-
des. This compartment is bounded by the clavicle (in-
feriorly), the anterior border of the trapezius (posteriorly),
the posterior border of the SCM (anteriorly). It is divi-
ded into sublevels VA (lying above a transverse plane
marking the inferior border of the anterior cricoid ar-
ch) and VB (below the aforementioned plane). 
• Level VI: includes the anterior compartment lymph
nodes. This compartment is bounded by the common
carotid arteries (laterally), the hyoid (superiorly), the su-
prasternal notch (inferiorly). 
• Level VII: includes lymph node of the anterior-
superior mediastinum (infraclavicular and anterior me-
diastinal or thymic).
All these node stations are grouped in four com-
partments (10) and in agreement with the American
Head and Neck Society (AHNS) and the American Aca-
demy of Otolaryngology-Head and Neck Surgery (AAO-
HNS) the neck dissection is classified as follows (11) (Fig.
2):
Central Neck Dissection (CND) refers to removal
only of the node group of level VI. 
Radical Neck Dissection (RND) refers to removal of
all ipsilateral cervical lymph node groups from levels I
through V, together with SAN, sternocleidomastoid mu-
scle (SCM) and internal jugular vein (IJV). 
Modified Radical Neck Dissection (MRND) refers
to removal of all lymph node groups routinely removed
in a RND, but with preservation of one or more non-
lymphatic structures (SAN, SCM and IJV) (Fig. 3).
Selective Neck Dissection (SND) (together with the
use of parentheses to denote the levels or sublevels re-
moved) refers to cervical lymphadenectomy with pre-
servation of one or more lymph node groups that are
routinely removed in a RND. Thus for oral cavity can-
cers, SND (I-III) is commonly performed. For
oropharyngeal, hypopharyngeal and laryngeal cancers,
SND (II-IV) is the procedure of choice. 
Extended Neck Dissection refers to removal of one
or more additional lymph node groups or non-lympha-
Fig. 2 - A (central compartment): flanked by the carotid sheaths,
from the hyoid bone and superior thyroid vessels of each side
down to the brachiocephalic vein. Including the pretracheal, pa-
ratracheal, and recurrent laryngeal lymphatic chain (level VI). 
B (ipilateral compartment) and C (contralateral compartment):
comprise the triangular region flanked by the internal jugular
vein in the midline (from the subclavian vein to the mastoid pro-
cess), the trapezoid muscle and spinal accessory nerve late-
ral-posteriorly and the subclavian vein inferiorly, and include the
lymph nodes of the jugular vein, those between the branches
of the cervical plexus and those of the supraclavicular groove
(levels II, III, IV, and V).
D (mediastinal compartment): represents the bilateral  one of
the trachea from the brachiocephalic vein down to the tracheal
bifurcation and includes the anterior and posterior lymphatic
chains (level VII).
T: tumor. 
From: Goropoulos A, Karamoshos K, Christodoulou A, Ntitsias
T, Paulou K, Samaras S, Xirou P, Efstratiou I. World J. Surg. 28,
1275–1281, 2004.
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tic structures, or both, not encompassed by the RND.
Discussion
Papillary and follicular thyroid carcinomas are the
most common form of endocrine carcinomas. Lymph
node involvement seems to be a low risk factor for death,
but it increases the risk for loco-regional recurrences and
distant metastases. The central lymph node dissection
(CND) is recommended for high-risk patients, as ma-
le, patients more than 45 or less than 21 years old, pa-
pillary carcinomas greater than 1 cm or follicular carci-
noma more than 2 cm in diameter. Lateral lymph no-
de dissection is performed when the nodes of the cen-
tral compartment are involved, more than 3 cm in dia-
meter, and bulked; prophylactic lymphadenectomy is
useless. 
When thyroid carcinoma is known postoperatively,
re-operation depends on the cervical mass and of the re-
sults on the radioactive iodine treatment (12). In diffe-
rentiated thyroid carcinoma extensive node dissection at
presentation has been stated to offer no advantage ver-
sus selective lymphadenectomy, causing increased mor-
bidity. However, experienced surgeons report a low in-
cidence (less than 5%) of accessory spinal nerve and cer-
vical plexus permanent sequelae after functional neck dis-
section. In our opinion, patients with cervical lymph no-
de metastases require a complete loco-regional neck dis-
section. Systematic lymphadenectomy, performed by la-
teral neck plus upper anterior mediastinal dissection, can
yield a high disease-free survival (6). The benefits of
prophylactic central neck dissection (PCND) in patients
with differentiated thyroid carcinoma (DTC) have not
been clearly demonstrated so far and should be weighed
against the potential risks of the procedure (i.e.: recur-
rent laryngeal nerve injuries and parathyroid ablation).
After total thyroidectomy (TT) for DTC, PCND does
not increase recurrent laryngeal nerve morbidity but it
is responsible for a high rate of hypoparathyroidism, espe-
cially in the early postoperative course. Even taking in-
to account the possible benefits, the results make it dif-
ficult to advocate PCND as a routine procedure in all
patients presenting a DTC (13, 14). This approach could
change in some conditions, specially for patients at hi-
gh risk for contralateral nodal recurrence considering the
nodal recurrence at the contralateral cervical side as a poor
prognosis for patients with papillary thyroid cancer. The
possibility to employ a bilateral modified radical neck dis-
section (MRND) during initial surgical management is
thus considered to improve the prognosis of some pa-
Fig. 3 - Modified radical neck dissection.




Tumor extension over the isthmus
Extracapsular adhesion or invasion to surrounding tissues
Presence of gross nodal metastasis at initial surgery
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pillary carcinoma patients at risk for recurrence in the
contralateral cervical lymph nodes (15). The risk factors
for contralateral nodal recurrence were male sex, large pri-
mary tumor, tumor extension over the isthmus, extra-
capsular adhesion or invasion to surrounding tissues, and
the presence of gross nodal metastasis at initial surgery
(16) (Tab. 1). Lateral neck compartmental lymph node
dissection should be performed for patients with biopsy
proven metastatic cervical lymphadenopathy detected cli-
nically or by imaging, especially when they are likely to
fail radioactive iodine treatment based on lymph node
size, number, or other factors, such as aggressive histo-
logy of the primary tumor (7). Regarding the role of no-
de-picking the functional compartmental en-bloc dis-
section is favoured over selective dissection (berry picking)
with limited data suggesting improved mortality. Most
surgeons endorse complete ipsilateral compartmental dis-
section of involved compartments with persistent/re-
current disease while sparing vital structures as opposed
to berry picking or selective lymph node resection pro-
cedures, because microscopic lymph node metastases are
commonly more extensive than would appear from ima-
ging studies alone (7). Today the role of the sentinel lymph
node has to be avoided considering the possibility of skip
metastases in thyroid cancer (17). It is not clear that treat-
ment of locoregional disease is beneficial in the setting
of untreatable distant metastases, except for possible pal-
liation of symptoms or prevention of airway or aero-di-
gestive obstruction. Impalpable metastatic lymph nodes,
visualized on ultrasound or other anatomic imaging mo-
dality, have survived initial 131I therapy and should be
considered for resection (7).
Papillary thyroid carcinoma
Papillary thyroid carcinoma (PTC) is well known as
a lymphotropic type of cancer. In more than 50 percent
of all cases it metastasizes first and mainly in regional
lymph nodes. In PTC lymphnode metastases at pre-
sentation do not seem to adversely affect survival, but
do increase the risk of loco-regional tumor recurrence.
The value of systematic versus selective lymphadenec-
tomy is far less standardized, whereas the role of posto-
perative radioiodine in preventing either nodal recurrence
or cancer death remains controversial. Total thyroidec-
tomy (TT) is the treatment of choice in the management
of PTC, while the efficacy and safety of neck dissection
(e.g.: modified radical neck dissection, MRND) are still
debate (6, 18). The benefits of prophylactic central neck
dissection (PCND) in patients with PTC have not been
clearly demonstrated so far and should be weighed again-
st the potential risks of the procedure as laryngeal ner-
ve palsy and permanent ipoparathyroidsm (5% and 4%
respectively) (13, 19). After TT with MRND of the af-
fected side, nodal recurrence at the contralateral cervi-
cal side indicates a poor prognosis for patients with PTC,
thus some surgeons made bilateral MRND to improve
the prognosis in patients at risk for contralateral nodal
recurrence (15) (Tab. 1). In PTC extensive lymphnode
dissection at presentation has been stated to offer no ad-
vantage versus selective lymphadenectomy, causing in-
creased morbidity. However, experienced surgeons re-
port a low incidence (less than 5%) of nerve injuries af-
ter functional neck dissection. Patients with cervical
lymph node metastases require a complete loco-regio-
nal neck dissection (6). The literature data revealed bet-
ter survival rates and quality of life in patients who had
undergone TT with MRND in comparison with those
ones who had undergone TT with berry picking (BP).
MRND is an effective and comparatively safe procedure
for the treatment of patients with PTC and regional
lymph nodes metastases. If adequately performed it en-
sures better quality of life, longer survival and impro-
ves further control on distant metastases (16). After TT
for PTC, PCND does not increase recurrent laryngeal
nerve morbidity but it is responsible for a high rate of
hypoparathyroidism, especially in the early postopera-
tive course. Even taking into account the possible be-
nefits, the results make it difficult to advocate PCND
as a routine procedure in all patients presenting a PTC.
Bilateral MRND should be considered for patients with
papillary carcinoma who show risk factors for contrala-
teral nodal recurrence, as it could prevent a second ope-
ration and may improve their outcome. 
Follicular thyroid carcinoma
Follicular thyroid carcinoma (FTC) is the next mo-
st common type of thyroid cancer. FTC is much less
common than papillary thyroid cancer, making up about
5% to 10% of thyroid cancers. It is more common in
countries where people don’t get enough iodine in their
diet. These cancers usually remain in the thyroid gland
but can spread to other parts of the body, such as lungs
and bone. Lymph node involvement is far less common
than in papillary carcinoma (8-13%). The prognosis of
follicular carcinoma is probably the same or slightly wor-
se than that of papillary carcinoma, and is related to de-
gree of vascular invasion and to the age (> 40) (20). The
diagnosis of FTC cannot always be made at the time of
initial surgery: usually are solid tumors within the thy-
roid and only 10% are multifocal or involve regional
lymph nodes (21, 22). The optimal treatment of lymph
node metastases has not yet been defined. Two trends
are evident concerning lymphadenectomy: the first one
suggests routine lymphadenectomy, the second supports
lymphadenectomy by necessity. The lymphadenectomy
is recommended only in the presence of clinical evidence
of lymph node involvement (23). 
Medullary thyroid carcinoma
Medullary thyroid carcinoma (MTC) is a tumor de-
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rived from the parafollicular C cells; it represents 3% to
10 % of thyroid gland malignancies, but it is responsi-
ble for up to 13.4% of deaths that are caused by thyroid
cancer. MTC is usually considered an indolent disease,
with prolonged survival, although it spreads early in its
course to regional lymph nodes. Lymph node metasta-
ses were found in half of patients (Tab. 2). Contralate-
ral lymph nodes were found in upper of 30% of meta-
static patients with unilateral tumoral involvement of the
thyroid gland. A strong association was observed
between tumor size and lymph node involvement for both
hereditary and sporadic MTC. MTC patients treated by
TT and central and bilateral neck dissection, confirm that
lymph node metastases are frequent, being found in 55%
of MTC patients. Palpable MTC is reported to present
with cervical lymph node metastases in 25-82% of ca-
ses (19, 24). Several studies have shown that survival in
patients with MTC is dependent upon the adequacy of
the initial surgical procedure. For several reasons TT and
systematic CND is indicated for both the hereditary and
sporadic forms (24). TT and CND is recommended for
all MTC patients, but the indication for lateral neck dis-
section is still controversial. Some authors recommend
inclusion of the lateral neck dissection only if central or
lateral lymph node metastases are proved, or if the pri-
mary tumor is palpable. Others recommend systematic
lateral modified neck lymph node dissection, based on
the notoriously high incidence of regional lymphatic in-
volvement. Contralateral lymph node dissection may be
omitted only in patients with an unilateral thyroid tu-
mour and with no ipsilateral and central lymph node in-
volvement (Tab. 3). If mediastinal lymph node metastases
are proved, this compartment should be dissected syste-
matically (19, 25, 26). Thus, there is considerable con-
fusion regarding standard surgical treatment of MTC.
Furthermore, the incidence of complications related to
neck dissection, including hypoparathyroidism, recurrent
laryngeal nerve palsy, injury of the trachea or oesopha-
gus, has to be considered (27-30).
Conclusion
The extent of dissection and the experience of the
surgeon both play important roles in determining the
risk of surgical complications and recurrence. Com-
pleteness of surgical resection is an important deter-
minant of outcome, while residual metastatic lymph no-
des represent the most common site of disease recur-
rence. Several choices exist to prevent or to treat the neck
node diffusion of thyroid tumor. Considering the dif-
ferentiated thyroid cancers, the central compartment dis-
section can be achieved with low morbidity in expe-
rienced hands and should be considered for patients with
papillary thyroid carcinoma. Total thyroidectomy
without central node dissection may be appropriate for
follicular cancer, and when followed by radioactive io-
dine therapy, may provide an alternative approach for
papillary cancer. For those patients in whom nodal di-
sease is evident clinically, on preoperative ultrasound or
at the time of surgery, surgical resection may reduce the
risk of recurrence and possibly mortality. Surgery is fa-
voured for locoregional (i.e., cervical lymph nodes
and/or soft tissue tumor in the neck) recurrences, when
distant metastases are not present. Approximately one
TABLE 2 - LIMPH NODE METASTASIS IN MTC.
Central Ipsilateral Contralateral
compartment compartment compartment
Sporadic MTC 50% 57% 28%
Hereditary MTC 45% 36% 19%
(Reff. 19, 24)
TABLE 3 - LIMPH NODE METASTASIS IN MTC.
Neck dissection Society Surgical National Comprehensive German guidelines^
Oncology* Cancer Network°
Ipsilateral dissection Sporadic MTC + palpable tumor Sporadic MTC Sporadic MTC
Central compartment involvement (diameter > 1 cm)
Contralateral dissection ---- Bilateral disease Sporadic MTC + 
Ipsilateral involvement
Central compartment ---- Sporadic MTC (diameter < 1 cm) ----
Bilateral routine dissection ---- ---- Hereditary MTC
(Reff.: * = 31, 32; ° = 33; ^ = 29, 34
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